BACKGROUND: Human immunodeficiency virus (HIV) is now a complex, chronic disease requiring high quality care. Demonstration of quality HIV care requires uniform, aligned HIV care quality measurement. METHODS: In September 2007, the National Committee for Quality Assurance, under contract with the Health Resources and Services Administration, the Physician Consortium for Performance Improvement of the American Medical Association, and HIV Medicine Association of the Infectious Disease Society of America jointly sponsored and convened an expert panel as a HIV/AIDS Work Group to draft national HIV/AIDS performance measures for individual patient-level and system-level quality improvement. RESULTS: A total of 17 measures were developed to assess processes and outcomes of HIV/AIDS care for patients established in care, defined as having at least 2 visits in a 12-month period; thus, measures of HIV screening, testing, linkage, and access to care were not included. As a set, the measures assess a wide range of care, including patient retention, screening and prophylaxis for opportunistic infections, immunization, and initiation and monitoring of potent antiretroviral therapy. Since development, the HIV/AIDS measures' specifications have been fully determined and are being beta tested, and a majority have been endorsed by the National Quality Forum and have been adopted and implemented by the sponsoring organizations. CONCLUSIONS: HIV care quality measurement should be assessed with greater uniformity. The measures presented offer opportunities for such alignment.
BACKGROUND:Human immunodeficiency virus (HIV) is now a complex, chronic disease requiring high quality care. Demonstration of quality HIV care requires uniform, aligned HIV care quality measurement. METHODS: In September 2007, the National Committee for Quality Assurance, under contract with the Health Resources and Services Administration, the Physician Consortium for Performance Improvement of the American Medical Association, and HIV Medicine Association of the Infectious Disease Society of America jointly sponsored and convened an expert panel as a HIV/AIDS Work Group to draft national HIV/AIDS performance measures for individual patient-level and system-level quality improvement. RESULTS: A total of 17 measures were developed to assess processes and outcomes of HIV/AIDS care for patients established in care, defined as having at least 2 visits in a 12-month period; thus, measures of HIV screening, testing, linkage, and access to care were not included. As a set, the measures assess a wide range of care, including patient retention, screening and prophylaxis for opportunistic infections, immunization, and initiation and monitoring of potent antiretroviral therapy. Since development, the HIV/AIDS measures' specifications have been fully determined and are being beta tested, and a majority have been endorsed by the National Quality Forum and have been adopted and implemented by the sponsoring organizations. CONCLUSIONS:HIV care quality measurement should be assessed with greater uniformity. The measures presented offer opportunities for such alignment.
Authors: Elvin H Geng; David V Glidden; David R Bangsberg; Mwebesa Bosco Bwana; Nicholas Musinguzi; Denis Nash; John Z Metcalfe; Constantin T Yiannoutsos; Jeffrey N Martin; Maya L Petersen Journal: Am J Epidemiol Date: 2012-02-03 Impact factor: 4.897
Authors: Emily A Wang; Kathleen A McGinnis; Jessica B Long; Kathleen M Akgün; E Jennifer Edelman; David Rimland; Karen H Wang; Amy C Justice; David A Fiellin Journal: Am J Addict Date: 2015-02-06
Authors: Sara C Keller; Baligh R Yehia; Florence O Momplaisir; Michael G Eberhart; Amanda Share; Kathleen A Brady Journal: AIDS Patient Care STDS Date: 2014-03-21 Impact factor: 5.078
Authors: Catherine Maulsby; Kriti M Jain; Brian W Weir; Blessing Enobun; Melissa Werner; Morey Riordan; David R Holtgrave Journal: AIDS Behav Date: 2018-11
Authors: Keri N Althoff; Peter Rebeiro; John T Brooks; Kate Buchacz; Kelly Gebo; Jeffrey Martin; Robert Hogg; Jennifer E Thorne; Marina Klein; M John Gill; Timothy R Sterling; Baligh Yehia; Michael J Silverberg; Heidi Crane; Amy C Justice; Stephen J Gange; Richard Moore; Mari M Kitahata; Michael A Horberg Journal: Clin Infect Dis Date: 2014-01-23 Impact factor: 9.079
Authors: Peter F Rebeiro; Keri N Althoff; Bryan Lau; John Gill; Alison G Abraham; Michael A Horberg; Mari M Kitahata; Baligh R Yehia; Hasina Samji; John T Brooks; Kate Buchacz; Sonia Napravnik; Michael J Silverberg; Anita Rachlis; Kelly A Gebo; Timothy R Sterling; Richard D Moore; Stephen J Gange Journal: Am J Epidemiol Date: 2015-11-17 Impact factor: 4.897
Authors: David B Hanna; Kate Buchacz; Kelly A Gebo; Nancy A Hessol; Michael A Horberg; Lisa P Jacobson; Gregory D Kirk; Mari M Kitahata; P Todd Korthuis; Richard D Moore; Sonia Napravnik; Pragna Patel; Michael J Silverberg; Timothy R Sterling; James H Willig; Bryan Lau; Keri N Althoff; Heidi M Crane; Ann C Collier; Hasina Samji; Jennifer E Thorne; M John Gill; Marina B Klein; Jeffrey N Martin; Benigno Rodriguez; Sean B Rourke; Stephen J Gange Journal: Clin Infect Dis Date: 2013-01-11 Impact factor: 9.079